AstraZeneca
AZN
$70.30
Share price
0.24%
Change (1 day)
-7.27%
Change (1 year)
Categories
AstraZeneca (AZN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $61.95 B
According to AstraZeneca's latest financial reports the company's total liabilities are $61.95 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
AstraZeneca - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $61.95 B | 4.25% |
| 2022-12-31 | $59.42 B | -10.07% |
| 2021-12-31 | $66.07 B | 29.33% |
| 2020-12-31 | $51.09 B | 9.21% |
| 2019-12-31 | $46.78 B | 0.37% |
| 2018-12-31 | $46.60 B | -0.22% |
| 2017-12-31 | $46.71 B | 1.86% |
| 2016-12-31 | $45.85 B | 10.37% |
| 2015-12-31 | $41.54 B | 6.67% |
| 2014-12-31 | $38.94 B | 19.31% |
| 2013-12-31 | $32.64 B | 10.34% |
| 2012-12-31 | $29.58 B | 0.76% |
| 2011-12-31 | $29.36 B | -10.25% |
| 2010-12-31 | $32.71 B | -4.05% |
| 2009-12-31 | $34.09 B | 10.39% |
| 2008-12-31 | $30.89 B | -6.51% |
| 2007-12-31 | $33.04 B | 127.62% |
| 2006-12-31 | $14.51 B | 30.2% |
| 2005-12-31 | $11.14 B | -0.05% |
| 2004-12-31 | $11.15 B | 8.13% |
| 2003-12-31 | $10.31 B | -0.33% |
| 2002-12-31 | $10.35 B | 16.72% |
| 2001-12-31 | $8.86 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 59.45% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | -14.14% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 121.48% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | -44.50% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | -14.22% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | -7.01% | 🇫🇷 France |
 Biogen BIIB | $12.04 B | -80.56% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 11.44% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 6.01% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | -5.05% | 🇬🇧 UK |